Photo via Al Jazeera

WHO announces start of Ebola vaccine clinical trial in DR Congo

Read the original at Al Jazeera ↗
Cite

AFP. (2026, October 24). WHO announces start of Ebola vaccine clinical trial in DR Congo. Al Jazeera. https://www.aljazeera.com/news/2026/10/24/who-announces-start-of-ebola-vaccine-clinical-trial-in-dr-congo?traffic_source=rss

Dated from the outlet's own feed. Check the original for its byline.

Al Jazeera · collected 2026-10-24 · by AFP

Quick Summary

The World Health Organization announced the start of a clinical trial in Bunia, DRC, for an Ebola vaccine called Ervebo, which will test its effectiveness against the Bundibugyo strain of the virus. The trial involves a ring vaccination approach and includes two additional candidate vaccines: one from the University of Oxford and another from Moderna. Both vaccines are expected to enter the trial soon. This initiative aims to gather evidence on vaccine efficacy across various demographics, including pregnant women and children over 12 years old.
Written by AI on 2026-10-24, from this article's own text only (the story summary below draws on all the coverage).
See how they differ ↓

AI analysis

Story summary

As of October 24, 2026, the World Health Organization (WHO) began a clinical trial for an Ebola vaccine called Ervebo in Bunia, Democratic Republic of Congo (DRC), at the epicenter of the ongoing outbreak. The trial aims to determine if Ervebo offers any protection against the Bundibugyo strain of the virus, which is causing the current epidemic. Dr. Tedros Adhanom Ghebreyesus, WHO's director-general, announced this development on X (formerly Twitter), stating it would help assess vaccine candidates for the Bundibugyo virus.

The DRC declared its 17th Ebola outbreak in May 2026, which has since become the country’s worst on record with over 9,700 cases and more than 4,600 deaths. The WHO declared a public health emergency of international concern due to this outbreak spreading across four African countries, marking its widest geographical spread ever in Africa.

This trial is crucial as it could provide insights into whether existing vaccines can offer cross-protection against different Ebola strains, potentially aiding control measures and saving lives during the ongoing crisis.

Written for “Ebola Vaccine Clinical Trial In DRC” on 2026-11-20, grounded in this article and the 1 other(s) covering the same event.

How they differ

2 outlets covered “Ebola Vaccine Clinical Trial In DRC”.

What each outlet says

One AI summary per outlet of its latest article on this story, written from that article alone and checked against it. Open the article for the outlet's own words.

Al JazeeraThis outlet24 Oct

The World Health Organization announced the start of a clinical trial in Bunia, DRC, for an Ebola vaccine called Ervebo, which will test its effectiveness against the Bundibugyo strain of the virus. The trial involves a ring vaccination approach and includes two additional candidate vaccines: one from the University of Oxford and another from Moderna. Both vaccines are expected to enter the trial soon. This…

WHO announces start of Ebola vaccine clinical trial in DR Congo (this article)
Times of India24 Oct

The World Health Organization (WHO) has initiated a clinical trial called Tumaini in Bunia, DRC, to test whether the Ervebo Ebola vaccine can provide protection against the Bundibugyo strain of the virus. This follows the DRC's 17th and most severe Ebola outbreak, which has resulted in over 9,700 cases and more than 4,600 deaths since May. The trial will assess two additional experimental vaccines, one from Oxford…

Tumaini Trial Launch: WHO begins Ebola vaccine study in DRC; aims to protect against Bundibugyo strain →

Compared with similar articles

This article reads unscored and hedges 13% of its claims. Each row says how that neighbour differs.
Times of India
Hedges 3 of 18 claims Outlet record 59/100
The Guardian
Leans strongly left Hedges 3 of 47 claims Outlet record 64/100
“Article A discusses a third Ebola case in Kenya and US's role, while Article B reports on the start of an Ebola vaccine clinical trial in DR Congo.”
Deutsche Welle
Hedges 4 of 25 claims Outlet record 95/100
“Article A reports on Nigeria's first confirmed case of Ebola, while Article B discusses a WHO announcement about an Ebola vaccine clinical trial in DR Congo.”
Toronto Star
Hedges 1 of 2 claims Outlet record 64/100
“The articles describe different events: one is about a summit called by Africa CDC regarding Ebola in Nigeria, and the other is about WHO starting an Ebola vaccine trial in DR Congo.”
The Straits Times
Hedges 4 of 30 claims Outlet record 64/100
“The articles describe different events related to the Ebola outbreak but do not refer to the same specific incident.”
Toronto Star
Hedges 3 of 37 claims Outlet record 64/100
“The articles describe different aspects of the Ebola outbreak: one covers the spread and impact of the disease, while the other reports on a clinical trial for an Ebola vaccine.”
BBC News
Hedges 2 of 26 claims Outlet record 65/100
“The articles describe different events: one reports on a second Ebola death in Kenya, while the other announces an Ebola vaccine clinical trial in DR Congo.”
CBC News
Hedges 6 of 55 claims Outlet record 60/100
“The articles describe different aspects of the Ebola outbreak response in multiple countries, not a single specific incident.”
CBC News
Hedges 3 of 26 claims Outlet record 60/100
“Article A reports on the start of an Ebola vaccine clinical trial in DR Congo, while Article B discusses the overall progression and impact of the Ebola outbreak reaching 10,000 cases.”
The Hindu
Hedges 3 of 22 claims Outlet record 78/100
“The articles describe different aspects of the Ebola outbreak in Congo; one reports on the start of a clinical trial for an Ebola vaccine, while the other reports on the total number of cases reaching 10,000.”

Story

Ebola Vaccine Clinical Trial In DRC
Health · 2 article(s) covering the same event. See how they differ ↑
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
15
sentences that state something as happening or true
Uncertain
13%
2 of 15 hedged ("reportedly", "may", "according to")
Leaning
not political
takes no side on a contested political question
Publisher signals
60/100
Al Jazeera's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
2
Health
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-10-24 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

Al Jazeera · 6131 article(s) · 4 correction(s) detected
Running correction rate · 4 correction(s)

Who wrote this

AFP
1286 article(s) here · 1 carrying a prediction
Russian attacks damaged two of Kyiv's bridges, the mayor of the Ukrainian capital said on Friday (November 20, 2026), as Moscow launched a fresh wave of missiles and drones. "
2026-11-20 · assertive framing · Russian strikes damage two bridges in Kyiv: Mayor
His role will be filled in an acting capacity by current Defense Department Chief Information Officer Kirsten Davies, who has more appropriate credentials and has been Senate-confirmed, the source said.
The crisis, just like previous energy shocks, would certainly leave "lasting marks", the agency warned.
And the three-way meeting was set to last "no more than an hour", Kremlin spokesman Dmitry Peskov told Russian state media Wednesday (November 18, 2026).
Anthropic will begin trading on Thursday on the Nasdaq exchange after pricing its initial public offering at $83 a share, above its expected range and toppling SpaceX’s IPO to set a new record.
"I feel pretty foolish about having spent so much money and not seeing much for it, or maybe it would have been much worse without that," Mr. Musk said via videolink at the New York Times Dealbook conference.
The United States opposes "globalist regulation" of artificial intelligence in any form, President Donald Trump said on Thursday (November 19, 2026) ahead of talks with China's Xi Jinping, expected to broach the topic.
2026-11-19 · assertive framing · Trump says U.S. opposes 'globalist regulation' of AI
We will achieve 100% when we are repatriated with dignity,” Mr. Osman, 20, told AFP.
The Defence Ministry's body in charge of civilian affairs in Palestinian territories, Coordinator of Government Activities in the Territories (COGAT), said in a statement that Palestinians would again be free to move in the targeted areas near the Al-Bureij and Nuseirat refugee camps.
Anthropic has granted its underwriters a similar option, which would lift its total to about $93.5 billion.
Wire or desk byline, not an individual reporter.
Also by AFP
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 1286 articles by AFP →

Topics

DRC Ervebo The World Health Organization WHO the Democratic Republic of Congo

Subjects

WHO ORG · 6× DRC GPE · 4× 3Kenya GPE · 1× 3Nigeria GPE · 1× Bunia GPE · 1× DR Congo GPE · 1× Ituri GPE · 1× Tedros Adhanom Ghebreyesus PERSON · 1× The World Health Organization ORG · 1× the Democratic Republic of Congo GPE · 1×

Narrative

Recommended Stories list of 3 items- list 1 of 3Kenya announces second Ebola death, says ‘no evidence’ of community spread - list 2 of 3Nigeria’s first Ebola case matches DR Congo strain, health officials say - list 3 of 3WHO warns ‘more complex’ Ebola outbreak now present in 3 African countries Ervebo, a vaccine approved for use against the more common Zaire strain of Ebola, will be put through a full-scale human trial to see
framing: assertive · carried by 1 article(s) · first seen 2026-10-24
Recommended Stories list of 3 items- list 1 of 3Kenya announces second Ebola death, says ‘no evidence’ of community spread - list 2 of 3Nigeria’s first Ebola case matches DR Congo strain, health officials say - list 3 of 3WHO warns ‘more complex’ Ebola outbreak now present in 3 African countries Ervebo, a vaccine approved for use against the more common Zaire strain of Ebola, will be put through a full-scale human trial to see
2026-10-24 · Al Jazeera
WHO announces start of Ebola vaccine clinical trial in DR Congo · assertive framing

Claims (15 extracted, 2 hedged)

The World Health Organization (WHO) has announced the beginning of the first clinical trial of an Ebola vaccine in the outbreak that started in the Democratic Republic of Congo (DRC). asserted
that → announce → Congo
WHO’s director-general, Tedros Adhanom Ghebreyesus, said in a social media post on Friday that participants in the trial were vaccinated with the Ervebo vaccine in Bunia, the capital of the DRC’s northeastern Ituri province, which is the epicentre of the Ebola outbreak. asserted
which → say → outbreak
Recommended Stories list of 3 items- list 1 of 3Kenya announces second Ebola death, says ‘no evidence’ of community spread - list 2 of 3Nigeria’s first Ebola case matches DR Congo strain, health officials say - list 3 of 3WHO warns ‘more complex’ Ebola outbreak now present in 3 African countries Ervebo, a vaccine approved for use against the more common Zaire strain of Ebola, will be put through a full-scale human trial to see asserted
Ervebo → announce → trial
if it offers any cross-protection against the Bundibugyo species of Ebola that is behind the epidemic. asserted
that → offer → epidemic
“This trial will help us understand whether any of the vaccine candidates designed for Bundibugyo virus work,” the WHO chief said on X. “WHO is supporting this DRC-led effort to find answers and save lives,” he added. asserted
he → help → lives
The DRC declared its 17th and worst-ever Ebola outbreak in May and has since reported more than 9,700 cases, with the number of deaths exceeding 4,600. uncertain
number → declare → 4,600
The WHO, in response, triggered a public health emergency of international concern, its second-highest alert level. asserted
WHO → trigger → concern
The current outbreak has now been reported in four countries across eastern, central and western Africa, giving it the widest geographic spread of any Ebola outbreak on the continent to date. asserted
outbreak → report → date
The so-called Tumaini trial is a single trial framework that can test the safety, efficacy and immunogenicity of multiple vaccines. asserted
that → call → vaccines
The trial will use a ring vaccination approach: immunising contacts deemed to be at high risk of infection. asserted
trial → use → infection
The trial is set to incorporate two Bundibugyo-specific candidate vaccines, which are currently advancing through earlier-stage, smaller-scale clinical trials. asserted
which → set → trials
One is a ChAdOx1 adenoviral vector jab being developed by the University of Oxford; the other, by the US-based Moderna group, uses mRNA technology. asserted
other → develop → technology
Both have received funding from the Coalition for Epidemic Preparedness Innovations and are expected to enter the trial “shortly”, CEPI said in a statement. asserted
CEPI → receive → statement
The trial will include pregnant women and children aged 12 years and older, generating evidence for populations that are often excluded from clinical trials. asserted
that → include → trials
WHO emergencies director Chikwe Ihekweazu said the trial was set up to generate the rigorous evidence needed to determine whether the participating vaccines could protect people at risk. uncertain
vaccines → say → risk
Give feedback · no sign-in needed

No sign-in needed for now. Your note is sent without a name, so it cannot be answered.

History Support